The United States market remained flat over the last week but has seen an 18% increase over the past year, with earnings forecasted to grow by 16% annually. In such a landscape, growth companies with high insider ownership can be appealing as they often indicate strong confidence from those closest to the business and potential for robust performance.

Top 10 Growth Companies With High Insider Ownership In The United States

Name	Insider Ownership	Earnings Growth
Uxin (UXIN)	34.3%	69.4%
Upstart Holdings (UPST)	14.1%	59.9%
Super Micro Computer (SMCI)	12.8%	22.4%
Laird Superfood (LSF)	17.3%	115.9%
Karman Holdings (KRMN)	15.3%	52.6%
IREN (IREN)	13.6%	41.2%
ERock (EROC)	20.1%	56.3%
Corcept Therapeutics (CORT)	10.8%	44.8%
Cerebras Systems (CBRS)	11%	73.7%
AppLovin (APP)	23.2%	21.7%

Let's uncover some gems from our specialized screener.

Tempus AI (TEM)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Tempus AI, Inc. is a healthcare technology company operating in the United States with a market cap of $7.92 billion.

Operations: The company generates revenue from its Medical Labs & Research segment, amounting to $1.43 billion.

Insider Ownership: 32.8%

Return On Equity Forecast: 26% (2029 estimate)

Tempus AI's recent earnings report highlights significant growth, with second-quarter sales reaching US$289.33 million, up from US$241.84 million the previous year. Despite a net loss for the first half of 2026, the company improved its quarterly net income to US$5.64 million from a loss last year and raised its full-year revenue guidance to approximately US$1.6 billion, indicating strong growth potential. Tempus has not seen substantial insider buying recently but maintains high insider ownership, aligning management interests with shareholders as it focuses on innovative AI-driven healthcare solutions and strategic collaborations to bolster future revenue streams.

Arista Networks (ANET)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Arista Networks, Inc. develops, markets, and sells data-driven networking solutions for AI, data center, campus, and routing environments across various global regions with a market cap of $215.35 billion.

Operations: The company's revenue primarily comes from its Computer Networks segment, generating $9.71 billion.

Insider Ownership: 16.9%

Return On Equity Forecast: 31% (2029 estimate)

Arista Networks is experiencing robust growth, with earnings forecasted to increase by 16.9% annually, outpacing the US market average. Despite substantial insider selling recently, the company maintains high insider ownership, aligning management interests with shareholders. Arista's revenue for Q1 2026 was US$2.71 billion, up from US$2 billion a year ago, and it has been added to the Russell Top 50 Index. The company anticipates Q2 revenue of approximately US$2.8 billion.

Pinterest (PINS)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Pinterest, Inc. operates as a visual search and discovery platform across the United States, Canada, Europe, and other international markets with a market cap of approximately $13.68 billion.

Operations: The company generates revenue primarily from its Internet Information Providers segment, which amounts to approximately $4.37 billion.

Insider Ownership: 11.3%

Return On Equity Forecast: 36% (2029 estimate)

Pinterest is undergoing significant changes, with earnings expected to grow 22.6% annually, surpassing the US market average. Despite recent insider selling and a drop from multiple growth benchmarks, substantial insider ownership remains a key factor. The company announced a major $4 billion expansion with Amazon Web Services to enhance AI capabilities. Pinterest's Q1 2026 revenue reached US$1 billion but reported a net loss of US$73.59 million, indicating challenges alongside growth potential.

Taking Advantage

• Click this link to deep-dive into the 170 companies within our Fast Growing US Companies With High Insider Ownership screener.
• Interested In Other Possibilities? The end of cancer? These 33 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.